^○Kazuo Fujihara^1,2 (1.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan, 2.Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Japan)